SFRP5 and breast cancer: Previous studies has identified association of SFRP5 promoter hypermethylation with Acute myeloid leukemia[29], ovarian cancer[30], gastric cancer[31], oral squamous cell carcinoma[32], pancreatic cancer[33] and breast cancer[34].